Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance

Lena Kubiczkova, Fedor Kryukov, Ondřej Slabý, +10

Haematologica

EngineeringImmunologyPathologyInvasive BiomarkersHematological Malignancy +15

Centrosome associated genes pattern for risk sub-stratification in multiple myeloma

Fedor Kryukov, Pavel Němec, Lenka Radová, +6

Journal of Translational Medicine

Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting

Jana Čumová, Lucie Kovářová, Anna Potáčová, +5

International Journal of Hematology

Immunomagnetic SelectionCell TherapyImmunologyHematologyMyeloma Cells +8

Clinical implication of centrosome amplification and expression of centrosomal functional genes in multiple myeloma

Elena Dementyeva, Fedor Kryukov, Lenka Kubiczková, +8

Journal of Translational Medicine

Generation of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies

Darina Očadlíková, Fedor Kryukov, Klára Mollová, +7

Neoplasma

T-regulatory CellImmunologyAntigen ProcessingMyeloma-specific T CellsImmunotherapy +15

Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma

Lenka Bešše, Lenka Sedlaříková, Fedor Kryukov, +11

PLoS ONE

Hematological MalignancyNovel Putative MarkerOncologyAutoimmune DiseaseExtramedullary Myeloma +13

Nestin expression throughout multistep pathogenesis of multiple myeloma

Hana Šváchová, Fedor Kryukov, Elena Kryukova, +6

British Journal of Haematology

Cell cycle genes co-expression in multiple myeloma and plasma cell leukemia

Fedor Kryukov, Elena Dementyeva, Lenka Kubiczková, +9

Genomics

Hematological MalignancyChromatinCell DivisionGeneticsMultiple Myeloma +6

Centrosome amplification as a possible marker of mitotic disruptions and cellular carcinogenesis in multiple myeloma

Elena Dementyeva, Pavel Němec, Fedor Kryukov, +7

Leukemia Research

Hematological MalignancyChromatinTumor BiologyCell DivisionMedicine +9